Intensifica la transformacin de grasa en energa por ello es recomendado para personas que realizan actividad fsica
MONDAY, June 8, 2026 (HealthDay News) -- Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with reduced risks for thromboembolic events, emergency department use, and mortality among adults with obesity and autoimmune diseases (AIDs), according to a study published online June 6 in the Journal of the American Heart Association to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.Hao Dai, Ph.D., from the Indiana University School of Medicine in Indianapolis, and colleagues conducted a retrospective cohort study, which emulated a target trial using 2014 to 2024 electronic health record data to examine the association between GLP-1 RA use and major adverse cardiovascular and thromboembolic event risk among adults with obesity and AID
It's important to note that not all patients will require electrolyte supplementation this is primarily indicated for those experiencing significant gastrointestinal losses or inadequate intake, rather than as routine for all GLP-1 users
The gut microbiota also influences DA levels in the frontal cortex and striatum of rodents, and perturbations of the dopaminergic system are associated with mood-related disorders and cognitive dysfunction
Muhafaza Koullar ocuklarn ulaamayaca yerde saklaynz
